A new study protocol1 has been published on ClinicalTrials.gov detailing a trial initiated by Gnosis by Lesaffre partner Scotmann Pharmaceuticals, Pakistan, who will execute a large-scale, multi-centred study to examine the impact of the combination of Empagliflozin, an oral anti-diabetic, with vitamins K2 and D3 on various diabetic parameters, including quality-of-life. Scotmann Pharmaceuticals, Pakistan uses Gnosis…
The post New Vitamin K2 Clinical Trial Announced appeared first on Natural Pharmacy Business magazine.
Natural Pharmacy Business magazine Read More